Figure 1. Comparison of outcome in obese vs. non-obese patients (also appears within text).
| Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
| Journal website http://www.gastrores.org |
Original Article
Volume 6, Number 3, June 2013, pages 85-90
Obesity is Associated With Poor Surgical Outcome in Crohn’s Disease
Figure
Table
| Obese N = 36 (%) | Non-obese N = 54 (%) | P-value | |
|---|---|---|---|
| *P-value < 0.05; ∧P-value < 0.10. | |||
| BMI at surgery- median (range) | 32.3 (30.1 - 72.4) | 23.3 (18.5-28.5) | < 0.0001* |
| Age at surgery -median (range) | 45 (19 - 88) | 34 (19 - 75) | 0.001* |
| Disease duration-median (range) | 8 (1 - 41) | 9 (1 - 36) | 0.644 |
| Type of surgery | 0.079∧ | ||
| Fistulotomy, Seton Placment | 5 (14%) | 19 (35%) | 0.025* |
| Flap, Strictureplasty, Dilation | 6 (17%) | 6 (11%) | 0.448 |
| Resection, Diversion | 25 (69%) | 29 (53%) | 0.135 |
| Gender (male) | 9 (25%) | 21 (39%) | 0.171 |
| Ethnicity | 0.146 | ||
| Caucasian | 23 (64%) | 41 (76%) | 0.217 |
| African American | 9 (25%) | 12 (22%) | 0.76 |
| Tobacco Use | 9 (25%) | 13 (24%) | 0.92 |
| Moderate to Severe Disease | 17 (47%) | 19 (35%) | 0.254 |
| Steroid use | 10 (28%) | 19 (35%) | 0.461 |
| Immune modulator use | 28 (78%) | 48 (89%) | 0.154 |
| Azathioprine/6-MP | 13 (36%) | 21 (39%) | 0.79 |
| TNF blocker | 17 (47%) | 25 (46%) | 0.931 |
| Methotrexate | 1 (3%) | 8 (15%) | 0.08∧ |